Indications and Purposes
| 1 Indications And Usage Xalkori Is Indicated For The Treatment Of Patients With Metastatic Non-Small Cell Lung Cancer (Nsclc) Whose Tumors Are Anaplastic Lymphoma Kinase (Alk) Or Ros1-Positive As Detected By An Fda-Approved Test [See Dosage And Administration (2.1) ] . Xalkori Is A Kinase Inhibitor Indicated For The Treatment Of Patients With Metastatic Non-Small Cell Lung Cancer (Nsclc) Whose Tumors Are Anaplastic Lymphoma Kinase (Alk) Or Ros1-Positive As Detected By An Fda-Approved Test ( 1 , 2.1 ). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Crizotinib |
|
ZINC35902489 |